drugset / Trial / NCT03439436
A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.
RandomizedParallel-groupTriple-blindTreatment
Summary
An observer-blind, multi-centre, randomized, parallel-group study to compare the efficacy and safety of two formulations of xylometazoline/dexpanthenol nasal spray for the treatment of nasal congestion caused by an acute upper respiratory tract infection in adults.
Timeline
- Start
- 2018-02-26
- Primary completion
- 2018-05-02
- Completion
- 2018-05-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexpanthenol | Small molecule | 5 mg | Intranasal |
| Subject | Xylometazoline | Small molecule | 0.1 mg | Intranasal |